[Psychotropic drug research in Germany: challenges of early benefit assessment and precision psychiatry].

Gründer G, Bielen H, Broich K, Lipinski S, Rinke W, Röseler A, Schuier M, von der Goltz C, Weiland M, Meyer-Lindenberg A, Reif A

Open source

DOI: 10.1007/s00115-026-01991-2
Published: 2026 Jul 6
Container: Der Nervenarzt
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00115-026-01991-2,
  title = {[Psychotropic drug research in Germany: challenges of early benefit assessment and precision psychiatry].},
  author = {Gründer G and Bielen H and Broich K and Lipinski S and Rinke W and Röseler A and Schuier M and von der Goltz C and Weiland M and Meyer-Lindenberg A and Reif A},
  year = {2026},
  journal = {Der Nervenarzt},
  doi = {10.1007/s00115-026-01991-2},
  url = {https://doi.org/10.1007/s00115-026-01991-2}
}

RIS

TY  - JOUR
TI  - [Psychotropic drug research in Germany: challenges of early benefit assessment and precision psychiatry].
AU  - Gründer G
AU  - Bielen H
AU  - Broich K
AU  - Lipinski S
AU  - Rinke W
AU  - Röseler A
AU  - Schuier M
AU  - von der Goltz C
AU  - Weiland M
AU  - Meyer-Lindenberg A
AU  - Reif A
PY  - 2026
JO  - Der Nervenarzt
DO  - 10.1007/s00115-026-01991-2
UR  - https://doi.org/10.1007/s00115-026-01991-2
ER  -

APA

G, G., H, B., K, B., S, L., W, R., A, R., M, S., C, V. D. G., M, W., A, M., & A, R. (2026). [Psychotropic drug research in Germany: challenges of early benefit assessment and precision psychiatry].. Der Nervenarzt. https://doi.org/10.1007/s00115-026-01991-2

Source records

pubmed · retrieved 2026-11-10T19:01:43.743Z